Patent ID: 8541406
Filing Date: 2013-09-24
Classification: A61K,A61P

Abstract:
1. A pharmaceutical composition comprising a therapeutically effective amount of a 1,2,4-thiadiazole derivative according to the structural formula (A) wherein the divalent group schematically represented by the structural formula (A′) includes an optionally mono-substituted or poly-substituted, saturated or partly unsaturated heterocyclic ring with at least two nitrogen atoms in the said heterocyclic ring and with a total of 5 to 7 atoms in the said heterocyclic ring, and further wherein: R n is selected from the group consisting of 0, 1, 2 and 3; R R R X is a linking moiety selected from the group consisting of —C(═O)—; —S(═O)  group of structural formula (A); and divalent saturated or unsaturated heterocyclic groups having from 2 to 6 carbon atoms and from 1 to 3 heteroatoms independently selected from the group consisting of oxygen, sulfur and nitrogen in the said heterocyclic group; or X together with one of R or a stereoisomer or solvate thereof, or a pharmaceutically acceptable salt thereof, in combination with one or more pharmaceutically acceptable excipients.